Partnering Through Membership For A Better Pharmaceutical Industry – Part Two: California Life Sciences

The pharmaceutical industry relies on valuable organizations and advocacy groups that drive progress for both members and patients. In this occasional series, we explore these organizations and their missions. Our first entry covered the European Fine Chemicals Group (EFCG) and its parent, the European Chemical Industry Council (Cefic). In this second installment, we delve into California Life Sciences (CLS), a leader in fostering a thriving life sciences ecosystem across California.

Founded as the Bay Area Bioscience Association in 1999, CLS now supports statewide growth with initiatives spanning advocacy, education, and talent development. By connecting industry, academia, and government, CLS fuels research, supports regulatory efficiency, builds a skilled workforce, and champions affordable access to innovative treatments. Through this work, CLS strengthens the life sciences sector, creates jobs, and improves patient outcomes, ensuring California’s role as a global leader in healthcare. Both entries and future ones can be found here.